Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop

Avian Pathology

Volumn 40, Issue 4, 2011, Pages 411-417

  Coppo, Mauricio J C ^a   Noormohammadi, Amir H ^a   Hartley, Carol A ^a   Gilkerson, James R ^a   Browning, Glenn F ^a   Devlin, Joanne M ^a,b  

^a THE UNIVERSITY OF MELBOURNE   (Australia)

^b Australian Poultry CRC   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; HERPES VACCINE; LIVE VACCINE; VIRULENCE FACTOR; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICK EMBRYO; CHICKEN; COMPARATIVE STUDY; DRUG ADMINISTRATION ROUTE; FEMALE; GENE DELETION; GENETICS; GERMFREE ANIMAL; HERPES VIRUS INFECTION; ILTOVIRUS; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; VACCINATION; VIROLOGY; VIRUS REPLICATION; WEIGHT GAIN;

ANIMALS; CHICK EMBRYO; CHICKENS; DRUG ADMINISTRATION ROUTES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; HERPESVIRUS VACCINES; MALE; OPHTHALMIC SOLUTIONS; POULTRY DISEASES; SEQUENCE DELETION; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRULENCE FACTORS; VIRUS REPLICATION; WEIGHT GAIN;

AVES; GALLID HERPESVIRUS 1; GALLUS GALLUS;

EID: 79960558874     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079457.2011.588686     Document Type: Article

References (38)

1. Andreasen, J.R., Jr, Glisson, J.R., Goodwin, M.A., Resurreccion, R.S., Villegas, P. & Brown, J. (1989). Studies of infectious laryngotracheitis vaccines: immunity in layers. Avian Diseases, 33, 524-530.
2. Bagust, T.J. (1986). Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken 4. Latency establishment by wild and vaccine strains of ILT virus. Avian Pathology, 15, 581-595.
3. Bagust, T.J. & Johnson, M.A. (1995). Avian infectious laryngotracheitis: virus-host interactions in relation to prospects of eradication. Avian Pathology, 24, 373-391.
4. Bagust, T.J. & McGavin, D.R. (1991). Low virulence laryngotracheitis (ILT) virus for vaccinating birds. Patent Publication No. WO/1991/002053. W.I.P. Organisation, Arthur Webster Pty Ltd, Sydney, Australia.
5. Blacker, H., Kirkpatrick, N., Rubite, A., O'Rourke, D. & Noormohammadi, A.H. (2011). Epidemiology of recent outbreaks of infectious laryngotracheitis in poultry in Australia. Australian Veterinary Journal, 89, 89-94.
6. Brandly, C.A. & Bushnell, L.D. (1934). A report of some investigations of infectious laryngotracheitis. Poultry Science, 13, 212-217.
7. Davison, S., Gingerich, E.N., Casavant, S. & Eckroade, R.J. (2006). Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge. Avian Diseases, 50, 50-54.
8. Devlin, J.M., Browning, G.F., Gilkerson, J.R., Fenton, S.P. & Hartley, C.A. (2008). Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol. Avian Pathology, 37, 83-88.
9. Devlin, J.M., Browning, G.F., Hartley, C.A. & Gilkerson, J.R. (2007). Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine, 25, 3561-3566.
10. Devlin, J.M., Browning, G.F., Hartley, C.A., Kirkpatrick, N.C., Mahmoudian, A., Noormohammadi, A.H. & Gilkerson, J.R. (2006). Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. Journal of General Virology, 87, 2839-2847.
11. Devlin, J.M., Viejo-Borbolla, A., Browning, G.F., Noormohammadi, A.H., Gilkerson, J.R., Alcami, A. & Hartley, C.A. (2010). Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine, 28, 1325-1332.
12. Fahey, K.J. & York, J.J. (1990). The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. Journal of General Virology, 71, 2401-2405.
13. Fahey, K.J., Bagust, T.J. & York, J.J. (1983). Laryngotracheitis herpesvirus infection in the chicken: the role of humoral antibody in immunity to a graded challenge infection. Avian Pathology, 12, 505-514.
14. Fahey, K.J., York, J.J. & Bagust, T.J. (1984). Laryngotracheitis herpesvirus infection in the chicken. II. The adoptive transfer of resistance with immune spleen cells. Avian Pathology, 13, 265-275.
15. Garcia, M. & Riblet, S.M. (2001). Characterization of infectious laryngotracheitis virus isolates: demonstration of viral subpopulations within vaccine preparations. Avian Diseases, 45, 558-566.
16. Guy, J. & García, M. (2008). Laryngotracheitis. In Y.M. Saif, A.M. Fadly, J.R. Glisson, L.L. McDougald, L.K. Nolan & D.E. Swayne (Eds.). Diseases of Poultry 12th edn (pp. 137-152). Ames, IA: Blackwell Publishing.
17. Guy, J.S., Barnes, H.J. & Morgan, L.M. (1990). Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Diseases, 34, 106-113.
18. Guy, J.S., Barnes, H.J. & Smith, L. (1991). Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Diseases, 35, 348-355.
19. Helferich, D., Veits, J., Teifke, J.P., Mettenleiter, T.C. & Fuchs, W. (2007). The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens. Journal of General Virology, 88, 732-742.
20. Honda, T., Okamura, H., Taneno, A., Yamada, S. & Takahashi, E. (1994). The role of cell-mediated immunity in chickens inoculated with the cell-associated vaccine of attenuated infectious laryngotracheitis virus. Journal of Veterinary Medical Science, 56, 1051-1055.
21. Hughes, C.S., Gaskell, R.M., Jones, R.C., Bradbury, J.M. & Jordan, F.T.W. (1989). Effects of certain stress factors on the re-excretion of infectious laryngotracheitis virus from latently infected carrier birds. Research in Veterinary Science, 46, 274-276.
22. Hughes, C.S., Williams, R.A., Gaskell, R.M., Jordan, F.T.W., Bradbury, J.M., Bennett, M. & Jones, R.C. (1991). Latency and reactivation of infectious laryngotracheitis vaccine virus. Archives of Virology, 121, 213-218.
23. Johnson, D.I., Vagnozzi, A., Dorea, F., Riblet, S.M., Mundt, A., Zavala, G. & García, M. (2010). Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines. Avian Diseases, 54, 1251-1259.
24. Kirkpatrick, N.C., Mahmoudian, A., Colson, C.A., Devlin, J.M. & Noormohammadi, A.H. (2006). Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis. Avian Pathology, 35, 449-453.
25. May, H.G. & Titsler, R.P. (1925). Tracheolaryngotracheitis in poultry. Journal of the American Veterinary Medical Association, 67, 229-231.
26. Mebatsion, T., Melson, L. & Hein, R. (2008). A novel HVT-based recombinant vaccine (Innovax-ILT) to simultaneously control infectious laryngotracheitis and Marek's disease in chickens. In Proceedings of the XXIII World's Poultry Conference (pp. 40-42). Brisbane, Queensland, Australia.
27. Mundt, A., Mundt, E. & García, M. (2010). Generation of a glycoprotein J deletion mutant of infectious laryngotracheitis virus (ILTV) as potential vaccine for DIVA approach. In Proceedings of the 2010 AAAP Annual meeting (pp. 9245). Atlanta GA, USA.
28. Neff, C., Suddler, C. & Hoop, R.K. (2008). Characterization of western European field isolates and vaccine strains of avian infectious laryngotracheitis virus by restriction fragment length polymorphism and sequence analysis. Avian Diseases, 52, 278-283.
29. Ojkic, D., Swinton, J., Vallieres, M., Martin, E., Shapiro, J., Sanei, B. & Binnington, B. (2006). Characterization of field isolates of infectious laryngotracheitis from Ontario. Avian Pathology, 35, 286-292.
30. Oldoni, I. & García, M. (2007). Characterization of infectious laryngotracheitis virus isolates from the United States by polymerase chain reaction and restriction fragment length polymorphism of multiple genome regions. Avian Pathology, 36, 167-176.
31. Oldoni, I., Rodriguez-Avila, A., Riblet, S. & Garcia, M. (2008). Characterization of infectious laryngotracheitis virus (ILTV) isolates from commercial poultry by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Avian Diseases, 52, 59-63.
32. Oldoni, I., Rodriguez-Avila, A., Riblet, S., Zavala, G. & Garcia, M. (2009). Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States. Avian Pathology, 38, 47-53.
33. Pavlova, S.P., Veits, J., Blohm, U., Maresch, C., Mettenleiter, T.C. & Fuchs, W. (2010). In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus. Journal of General Virology, 91, 847.
34. Purcel, D.A. & Surman, P.G. (1974). Letter: aerosol administration of the SA-2 vaccine strain of infectious laryngotracheitis virus. Australian Veterinary Journal, 50, 419-420.
35. Rodriguez, A. & García, M. (2008). Challenge study to evaluate vaccine protection against infectious laryngotracheitis virus (ILTV). Poultry Science, 87, 155.
36. Rodriguez-Avila, A., Oldoni, I., Riblet, S. & García, M. (2008). Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent strain from the United States. Avian Pathology, 37, 287-292.
37. Sun, H.-L., Wang, Y.-F., Tong, G.-Z., Zhang, P.-J., Miao, D.-Y., Zhi, H.-D., Wang, M. & Wang, M. (2008). Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus. Avian Diseases, 52, 111-117.
38. Williams, R.A., Bennett, M., Bradbury, J.M., Gaskell, R.M., Jones, R.C. & Jordan, F.T.W. (1992). Demonstration of sites of latency of infectious laryngotracheitis virus using the polymerase chain reaction. Journal of General Virology, 73, 2415-2420.